34915005: Pyridostigmine bromide (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Acetylcholinesterase inhibitor\Reversible anticholinesterase\Pyridostigmine bromide

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Autonomic agent (substance)\Parasympathomimetic agent (substance)\Acetylcholinesterase inhibitor\Reversible anticholinesterase\Pyridostigmine bromide

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

58268013 Pyridostigmine bromide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

766495018 Pyridostigmine bromide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

52201000195118 piridostigmina bromuro it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

12391000188115 pyridostigmine bromure fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

836791000172111 bromure de pyridostigmine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

66521000195119 Pyridostigmin bromid de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

236191000195111 Pyridostigminbromid de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Pyridostigmine bromide	Is a	Product containing pyridostigmine (medicinal product)	false	Inferred relationship	Some
Pyridostigmine bromide	Is a	Pyridostigmine (substance)	false	Inferred relationship	Some
Pyridostigmine bromide	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Acetylcholine receptor agonist (disposition)	false	Inferred relationship	Some
Pyridostigmine bromide	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Cholinesterase inhibitor	false	Inferred relationship	Some
Pyridostigmine bromide	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Pyridostigmine (substance)	true	Inferred relationship	Some
Pyridostigmine bromide	Is a	Reversible anticholinesterase	true	Inferred relationship	Some
Pyridostigmine bromide	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Reversible anticholinesterase	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Pyridostigmine bromide 5mg/mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pyridostigmine bromide	Inferred relationship	Some
Pyridostigmine bromide 60mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pyridostigmine bromide	Inferred relationship	Some
Pyridostigmine bromide 180mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pyridostigmine bromide	Inferred relationship	Some
Pyridostigmine bromide 60mg/5mL syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pyridostigmine bromide	Inferred relationship	Some
Pyridostigmine bromide 10mg/2mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pyridostigmine bromide	Inferred relationship	Some
Product containing precisely pyridostigmine bromide 60 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pyridostigmine bromide	Inferred relationship	Some
Pyridostigmine bromide 5mg/mL injection solution 2mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pyridostigmine bromide	Inferred relationship	Some
Product containing precisely pyridostigmine bromide 60 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pyridostigmine bromide	Inferred relationship	Some	1
Product containing precisely pyridostigmine bromide 60 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pyridostigmine bromide	Inferred relationship	Some	1
Product containing precisely pyridostigmine bromide 180 milligram/1 each prolonged-release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pyridostigmine bromide	Inferred relationship	Some	1
Product containing precisely pyridostigmine bromide 180 milligram/1 each prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Pyridostigmine bromide	Inferred relationship	Some	1
Product containing precisely pyridostigmine bromide 60 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Pyridostigmine bromide	Inferred relationship	Some	1
Product containing precisely pyridostigmine bromide 12 milligram/1 milliliter conventional release oral solution (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pyridostigmine bromide	Inferred relationship	Some	1
Product containing precisely pyridostigmine bromide 12 milligram/1 milliliter conventional release oral solution (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Pyridostigmine bromide	Inferred relationship	Some	1
Pyridostigmine bromide 5 mg/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Pyridostigmine bromide	Inferred relationship	Some	1
Pyridostigmine bromide 5 mg/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pyridostigmine bromide	Inferred relationship	Some	1

This concept is not in any reference sets